Approval rating: how do the EMA and FDA compare? | Cancer World Archive
Oncology Clinical Trials During the COVID-19 Pandemic
Material and information about the upcoming CTIS from EMA – Ascro
Clinical trials in the EU - Laura Pioppo
Clinical Trial Disclosure: Summary of the main requirements in EU/EEA... | Download Table
CTIS for sponsors - EMA
Characteristics of Single Pivotal Trials Supporting Regulatory Approvals of Novel Non‐orphan, Non‐oncology Drugs in the European Union and United States from 2012−2016 - Morant - 2019 - Clinical and Translational Science - Wiley Online Library
Lay Summaries of Clinical Study Results: An Overview | SpringerLink
EU's Clinical Trials Regulation and portal goes live 31 January
Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States - Cytotherapy
Clinical Trial Regulation
New Clinical Trials Information System - NREC
EU Medicines Agency on Twitter: "In a letter published today, @EU_Commission, #EMA and the Heads of Medicines Agencies remind all sponsors of #ClinicalTrials conducted in the 🇪🇺 to make results of concluded
EMA calls for 'stakeholder' input on design of new clinical trials database
Call for all sponsors to publish clinical trial results in EU database | European Medicines Agency
EudraVigilance system overview | European Medicines Agency
Clinical Trial Regulation Update - PharSafer® - Specialists in Global Clinical and Post Marketing Drug Safety
Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency | Trials | Full Text
EU Clinical Trials Regulation (EU-CTR) enters application on 31 January 2022
clinical-trials-portal - IDMP1
Welcome to CTIS
EMA's Clinical Trials Information System (CTIS) goes live – EJP RD – European Joint Programme on Rare Diseases
